Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

317-34-0

Aminophylline

317-34-0
71963-77-4

Artemether

71963-77-4
88495-63-0

Artesunate

88495-63-0
64228-81-5

Atracurium Besylate

64228-81-5
66376-36-1

Alendronic Acid

66376-36-1
82248-59-7

Atomoxetine HCl

82248-59-7
4330-99-8

Alimemazine tartrate

4330-99-8
140-67-0

4-Allylanisole

140-67-0
14028-44-5

Amoxapine

14028-44-5
24916-51-6

Acetyl spiramycin mixture

24916-51-6
86-42-0

Amodiaquine

86-42-0
37517-30-9

Acebutolol

37517-30-9
89-57-6

5-Aminosalicylic Acid

89-57-6
665-66-7

1-Adamantanamine HCl

665-66-7
551-16-6

6-Aminopenicillanic Acid

551-16-6
69-53-4

Ampicillin

69-53-4
497-76-7

Arbutin

497-76-7
1078-38-2

Acetyl Isoniazid

1078-38-2
53164-05-9

Acemetacin

53164-05-9
154229-18-2

Abiraterone acetate

154229-18-2